HER2+ breast cancer and TNBC are well known to be associated with increased cancer cell proliferation and genomic instability but interestingly, TIL levels were found to be higher in both HER2+ breast cancer and TNBC than in ER+/HER2− tumors [1]. Here, ESR1 is linked to breast carcinoma.